The IL-6 response to  from primary reproductive epithelial cells is highly variable and may be involved in differential susceptibility to the immunopathological consequences of chlamydial infection by unknown
Cunningham et al. BMC Immunology 2013, 14:50
http://www.biomedcentral.com/1471-2172/14/50RESEARCH ARTICLE Open AccessThe IL-6 response to Chlamydia from primary
reproductive epithelial cells is highly variable and
may be involved in differential susceptibility to
the immunopathological consequences of
chlamydial infection
Kelly Cunningham1, Scott H Stansfield1, Pooja Patel1, Shruti Menon1, Vivian Kienzle1, John A Allan2,3
and Wilhelmina M Huston1,3*Abstract
Background: Chlamydia trachomatis infection results in reproductive damage in some women. The process and
factors involved in this immunopathology are not well understood. This study aimed to investigate the role of
primary human cellular responses to chlamydial stress response proteases and chlamydial infection to further
identify the immune processes involved in serious disease sequelae.
Results: Laboratory cell cultures and primary human reproductive epithelial cultures produced IL-6 in response
to chlamydial stress response proteases (CtHtrA and CtTsp), UV inactivated Chlamydia, and live Chlamydia. The
magnitude of the IL-6 response varied considerably (up to 1000 pg ml-1) across different primary human
reproductive cultures. Thus different levels of IL-6 production by reproductive epithelia may be a determinant in
disease outcome. Interestingly, co-culture models with either THP-1 cells or autologous primary human PBMC
generally resulted in increased levels of IL-6, except in the case of live Chlamydia where the level of IL-6 was
decreased compared to the epithelial cell culture only, suggesting this pathway may be able to be modulated by
live Chlamydia. PBMC responses to the stress response proteases (CtTsp and CtHtrA) did not significantly vary for
the different participant cohorts. Therefore, these proteases may possess conserved innate PAMPs. MAP kinases
appeared to be involved in this IL-6 induction from human cells. Finally, we also demonstrated that IL-6 was
induced by these proteins and Chlamydia from mouse primary reproductive cell cultures (BALB/C mice) and
mouse laboratory cell models.
Conclusions: We have demonstrated that IL-6 may be a key factor for the chlamydial disease outcome in humans,
given that primary human reproductive epithelial cell culture showed considerable variation in IL-6 response to
Chlamydia or chlamydial proteins, and that the presence of live Chlamydia (but not UV killed) during co-culture
resulted in a reduced IL-6 response suggesting this response may be moderated by the presence of the organism.
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Chlamydia trachomatis is the most prevalent sexually
transmitted bacterial infection worldwide [1]. The infec-
tion is frequently asymptomatic and can result in the
development of infertility in 4-20% of infected women
[2]. The infertility results from fallopian tube damage
such as scarring or complete tubal blockage. Several
different models have been proposed to explain the
mechanism of immunopathology. The hypersensitivity
to chlamydial HSP60 model is supported by evidence
including high titres of antibodies against this protein
being found in the serum of women with tubal infer-
tility, and immunopathological reactions to doses of this
protein in animal models subsequent to chlamydial
infections [3-6]. However cHSP60 antibodies found in
human sera have been reported to cross-react with other
bacterial species indicating the assays may not necessar-
ily have detected Chlamydia specific antibody titres [7].
Also, a molecular mimicry model where antibodies to
cHSP60 cross-react against human HSP60 has been pro-
posed, however recent data does not support that cHSP60
antibodies cross react with human HSP60 [8]. The ‘cellular
paradigm’ model is supported by a number of studies, this
model proposes that the reaction of the primarily infected
epithelia in the reproductive tract during chlamydial infec-
tion determines the disease outcome in each individual
[9]. A study using an ex vivo fallopian tube organ culture
model study demonstrated that IL-1(α and β) were pro-
duced by fallopian tube epithelial cells after live chlamyd-
ial infection [10]. The damage required live Chlamydia
and did not require immune cell infiltrates as these were
not present in this model [10]. One implication of this
study is that the induction of IL-1 and subsequent path-
ology may involve chlamydial effectors that are exported
from the Chlamydia vacuole. However, none of these
models has been unequivocally validated and it remains
uncertain why some (but not all) women develop repro-
ductive tract damage as a consequence of chlamydial
infection.
In order to further understand the chlamydial antigens
which may be involved in the development of disease we
have previously examined the serum immunoglobulin
response to chlamydial stress response proteases in
women with chlamydial infertility or treated infections
with no reported disease pathology [11]. Of particular
interest to us were two stress response proteases which
have been detected both inside the chlamydial inclusion
and in the host cell, CtHtrA and CtTsp [12-14]. Whilst
the presence or absence of serum antibodies against
these full length proteins (detected by Western blots)
was not significantly different between participant co-
horts (infertile or treated infections), there was a trend
towards different IgG subtype serological responses de-
pending on the participant disease cohort (CtTsp wasrecognised by IgG3 in the single resolved infection
cohort only) [11]. One possible explanation for the obser-
vation of differential immunoglobulin subclass responses
is that these proteins are associated with the different
immune responses which results in different disease
outcomes.
This project aimed to investigate the innate and adap-
tive cellular responses to these two proteases and chla-
mydial infections to test the hypothesis that they may be
antigens which are involved in driving the initial innate
pathological response to Chlamydia. In both laboratory
model cell cultures and primary reproductive cell culture
of epithelia or mononuclear cells we observed induction
of IL-6 in response to stimulation with these proteins or
with C. trachomatis. Interestingly, when lab models of
mononuclear cells and reproductive epithelia cells were
co-cultured we observed that the IL-6 response to live
Chlamydia was reduced compared to the epithelial cell
cultures only (for HeLa and Ishikawa, but not HEp-2).
This reduction did not occur for the individual proteins
or UV-killed Chlamydia. The amount of IL-6 produced
from primary reproductive epithelia varied greatly bet-
ween different participants. Combined these data imply
that amount of IL-6 produced from reproductive epithe-
lia during the Chlamydia infection may a key factor for
the disease outcome in women.Methods
Culture of laboratory cell lines
Human derived cell lines which are commonly used for
Chlamydia culture experiments were used, including HeLa
(cervical carcinoma cell line), Ishikawa (endometrial ade-
nocarcinoma with glandular properties [15]), Ecc-1 (endo-
metrial carcinoma cell line with luminal properties [16]),
and HEp-2 (male epidermoid laryngeal carcinoma cell
line). HEp-2, HeLa, and Ishikawa were cultured in DMEM
(Gibco) containing 10% foetal calf serum, streptomycin
(0.1 mg ml-1) and gentamycin (0.05 mg ml-1), at 37°C 5%
CO2. A human leukocytic mononuclear cell line, THP-1,
was also used. Ecc-1 and THP-1 cells were cultured in
RPMI (Gibco) containing 10% foetal calf serum, strep-
tomycin (0.1 mg ml-1) and gentamycin (0.05 mg ml-1), at
37°C 5% CO2. Mouse McCoy cells and mouse macro-
phages RAW264.7 were cultured in DMEM containing
5% FCS, streptomycin (0.1 mg ml-1), and gentamycin
(0.05 mg ml-1), in 5% CO2 at 37°C.Preparation of Chlamydia
C. trachomatis L2 (strain 434/Bu/ATCC: VR-902B) was
cultured using routine methods [12]. Ultraviolet (UV)
irradiated Chlamydia was prepared by placing an aliquot
in wells of a 48-well culture plate and placing the plate
4 cm from a UV light source for 40 min. Samples were
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monolayers.
Preparation of chlamydial Tsp and HtrA
Purified recombinant CtTsp and CtHtrA were used as
previously described [11]. Purified recombinant CmTsp
and CmHtrA were generated for the purposes of this
study. The methodology was essential the same as that
previously described for CtTsp and CtHtrA [11]. The
coding sequences for the proteins was generated by PCR
and cloned into the pET22b vector (Novagen) by restric-
tion enzyme digest using Escherichia (E.) coli JM109
cells. Primers used were: CmTsp Rev 5′ GCCTCGAGT
TGTGCGGGAGTCTTAATGAAGTTTGC 3′, CmTsp
Fwd 5′ GCGGATCCGTCAGCCCCCCTCCGACAACA
AGATG 3′, CmHtrA Fwd 5′ GCCCATGGGAATGTTG
GGCTATAGTGCGCCAAAGAAAG 3′, and CmHtrA
Rev 5′ GCAAGCTTTTCATCAGACTTTAAAACAAC
GAATCGAATG 3′. Clones were confirmed by restric-
tion enzyme digest and sequence analysis prior to trans-
formation into E. coli BL21 for IPTG induced expression
of the protein. The protein sequences were cloned in
frame with the vector encoded his-tag, and proteins
were purified using Talon affinity resin (Clontech,
Australia). Protein purity was monitored using SDS
PAGE and protein concentration determined using the
BCA reagent (SigmaAldrich, Australia), using previously
described methods [11].
Examination of cytokine responses to stimulation of
various laboratory cell lines
Epithelial cell lines were seeded at 10 000 cells/well in
96-well plates. In co-culture experiments, THP-1 cells
were also seeded at 5000 cells/well. Chlamydial proteins
were added at either 2 μg or 10 μg per well, while UV
killed Chlamydia (L2) and live Chlamydia (L2) were
added at 5 ul per well (1 × 106 ifu ml-1 stock). Superna-
tants were collected at 96 h after the addition of the
stimulants, unless otherwise specified. Samples were
frozen at −80°C until ready for assay for cytokine levels
by multi-plex bead array (or ELISA in the case of the
pathway inhibitor assays). Multi-plex suspension bead
array (Bio-Plex) was performed according to the manu-
facturer’s instructions (Bio-Rad, Australia).
Primary human reproductive tract cell culture
Primary human reproductive cell culture was conducted
on female reproductive tract tissue harvested from con-
sented participants who were undergoing hysterectomy for
benign reasons. This study was granted human research
ethics committee approval from UC Health Human
Research Ethics Committee (Approval number 1101) and
QUT Human Research Ethics Committee (Approval num-
ber 1100000267). Four participants were included for thisinvestigation and were included in the study due to their
low likelihood of a previous history of chlamydial disease,
all were undergoing benign hysterectomy. The participants
had an average age of 54 years (45–73), none were current
smokers, all self-reported to have never had a sexually
transmitted infection, all self reported to have never experi-
enced any fertility problems, ectopic pregnancy or pelvic
inflammatory disease, only one was currently using contra-
ceptive (QUTPRT05 (monofeme 24)), and three of the four
had less than five sexual partners in total.
Isolated endocervical and endometrial epithelia tissues
using scalpel shaving into fresh DMEM with 0.2% collage-
nase D (SigmaAldrich, Australia). The tissue was chopped
into fine pieces using a scalpel and further incubated for
10 mins in the DMEM with 0.2% collagenase D. The tis-
sue was then further processed by grinding between two
glass slides and incubated at 37°C with constant gentle
shaking for single cell suspension. Cells were centrifuged
at 1 000 × g for 10 mins at 37°C. the cell pellet was resus-
pended in DMEM with 0.2% collagenase D for a further
20 mins at 37°C with constant gentle shaking, prior to
harvesting the cell and resupension in 4 ml of DMEM
containing 2 U/ml DNAse, shaking gently for 2 mins, and
then addition of 4 ml of DMEM with 10% FCS to stop
DNAse activity. The cells were harvested by Centrifuge at
1000 × g for 10 min at 37°C and resuspended in red blood
cell lysis buffer (RBC lysis buffer recipe: NH4Cl 0.155 M,
NaHCO3 0.012 M, and EDTA 0.0001 M, pH 7.4) for 5
mins at 37°C. The cells were washed in PBS, filtered and
again harvested by centrifugation at 1000 × g for 10 mins
at 37°C prior to re-suspension in DMEM, 10% FCS,
glutamine (4 mmol/L), Gentamicin (0.05 mg ml-1) and
Strep (0.1 mg ml-1) and an aliquot of this suspension was
stained with trypan blue and counted using the haemocyt-
ometer to allow the cells to be plated. Cells were plated at
10 000 cells per well in 96 well plates for the simulation
experiments. Autologous PBMC were used in the co-
culture experiments (2000 cells per well), and these were
isolated as described below. Cultures were stimulated
exactly as described for the laboratory models. The super-
natants were harvested 96 h after stimulants added and
analysed using Bio-plex bead array.
Isolation and stimulation of peripheral blood mononuclear
cells
Consented voluntary participants provided blood col-
lected into EDTA tubes which were processed for PBMC
isolation. The participants consented to allow access to
their medical history, and also provided serum samples for
serological testing, in order to group them into cohorts,
infertile (attending fertility treatment clinic, known not to
have any tubal factor infertility), tubal factor infertility
(attending fertility treatment clinic, serologically positive
to as history of C. trachomatis infection by the bio-clone
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urine PCR diagnosed C. trachomatis genital tract infec-
tion). The infertile cohort was later categorised into C.
pneumoniae positive and negative cohorts using commer-
cial serological ELISAs for C. pneumoniae IgG (MEDAC
and Bioclone). The serum from these participants was also
used as part of a previously published study [11]. This study
has been approved by the QUT HREC approval number
0800000268, Nambour Sexual Health Clinic (EC2809);
Ipswich and West Moreton Sexual Health Clinic (10–09);
Gold Coast Sexual Health Clinic (200893); Cairns Sexual
Health Clinic (HREC/09/QCH/4-554); and Wesley IVF and
Gynaecology Clinic (2008/02).
Peripheral blood mononuclear cells were isolated using
a Ficoll gradient [17]. Cells were plated at 10 000 or 2000
cells per well (co-cultures) and stimulated and superna-
tants analysed as previously described.
Isolation and primary culture of cells derived from murine
tissues
Primary culture of mice tissue was conducted from 10
BALB/c mice. This work was approved by the QUT
Animal Research Ethics Committee (Approval number
1100000606). Mouse tissues were prepared by surgical
harvesting of the caudal lymph nodes and uterine horns
from freshly sacrificed naive mice. These caudal lymph
nodes and uterine horns were pooled and processed
from 10 mice. Single cell suspensions were prepared in a
protocol modified from the above human tissue proto-
col, stimulants added and cytokines measured at 96 h as
described above.
Cell signalling pathway inhibitor assays
In order to determine which signalling pathways were
involved in the production of IL-6 in response to chla-
mydial stimuli, HeLa cells (THP-1 cells), pre-incubated
with cell signalling pathway inhibitors, then stimulated
with Tsp, HtrA, UV-L2 or L2. The following inhibitors
were used in the experiments; Wedelolactone (IKK
inhibitor-2; Calbiochem, Australia), PD98059 (broad MEK
inhibitor; Calbiochem, Australia), U0126 (specific MEK1/
2 inhibitor; Calbiochem, Australia). PD98059 and U0126
were added to wells upon seeding, 24 h prior to addition
of chlamydial stimuli. All other inhibitors were added to
wells 1 h prior to addition of chlamydial stimuli. Ac-
YVAD-CHO was used at a concentration of 10 μM
(Garcia-Calvo et al., 1998), and replaced daily. Wedelolac-
tone was used at 2 μM concentration [18]. Both PD98059
and U0126 were used at a concentration of 10 μM. After
incubation, 100 ul supernatants were collected for IL-1β
ELISA assays at 24 h, while remaining supernatants for
IL-6 ELISA assays were collected at 96 h. IL-1β and IL-6
ELISA assays were conducted using commercial kits
(Invitrogen, Australia).Data analysis and statistics
When appropriate, mean cytokine concentration in
control wells (cells cultured with no stimuli) was sub-
tracted from that seen in stimulated cells, so as to account
for background cell cytokine levels. Differences between
the various treatments were compared using GraphPad
Prism software, and p-values were derived from unpaired
t-tests.
Results
Epithelia cells secrete IL-6 in response to Chlamydia
exported proteins which is differentially modulated by
co-cultures with THP-1 mononuclear cells
We conducted an initial experiment using common
laboratory model cell cultures, in order to test if the
chlamydial stress response proteases CtTsp and CtHtrA
have the potential to be PAMPs recognised by human
cells. The cells used were HeLa (cervical carcinoma cell
line), HEp-2 (male epidermoid laryngeal carcinoma cell
line), Ecc-1 (endometrial cancer cell line [16]), Ishikawa
(endometrial adenocarcinoma cell line [15]), and THP-1
(human leukemic monocytic cell line). The cells were
cultured for four days in the presence of CtTsp, or
CtHtrA, or live Chlamydia, or UV killed Chlamydia
(henceforth referred to as stimulants) and the superna-
tants were analysed for cytokines. All experiments were
conducted using THP-1 cells, epithelial cells, or in THP-
1/epithelial cell co-cultures (monolayers) (all in tripli-
cate). Figure 1 shows IL-6 detected at 96 h in response
to the proteins or Chlamydia. Other cytokines examined
(IL-1β, IL-10, IL-4, IL-12(p70), IL-13, IFNγ) were not
detectable at the 96 h time point in response to any of
these stimulants, indicating that IL-6 is part of a sus-
tained response to these PAMPs and Chlamydia. Inter-
estingly, some of the cytokines which were not detected
at 96 hrs in these experiments have been measured from
these cells in response to Chlamydia at earlier time
points in other published studies [19-21]. chlamydial
HSP60 was also tested and found to have a similar
cytokine stimulation profile to Tsp and HtrA (Additional
file 1: Figure S1) and was consistent with previous
reports [22,23].
We observed an increased level of IL-6 in response to
CtTsp, CtHtrA, and UV-killed Chlamydia stimulation of
HeLa and THP-1 co-cultures when compared to either
HeLa or THP-1 cells alone. Conversely, co-culture did
not enhance the secretion of IL-6 in response to live
Chlamydia. In fact, the presence of live Chlamydia dur-
ing the HeLa and THP-1 co-culture resulted in a much
lower amount of IL-6 secretion, with a reduction of
almost 27-fold when compared to IL-6 secretion from
mono-culture of HeLa cells with live Chlamydia
(Figure 1A). In contrast, IL-6 production was markedly
increased during the HEp-2 co-culture with THP-1 in
Figure 1 (See legend on next page.)
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Figure 1 IL-6 production by laboratory model epithelial cells and THP-1 cells to chlamydial antigens and Chlamydia. The graphs show
the supernatant concentration of IL-6 detected at 96 hrs after cells were stimulated with CtTsp, CtHtrA, UV killed Chlamydia, or live Chlamydia
(as labelled on the x-axis). HeLa cells A) are of cervical origin, HEp-2 cells are derived from male epidermoid cells B), while Ecc-1 C) and Ishikawa
D) cells are of endometrial origin. Each cell model was also co-cultured with THP-1 (culture conditions indicated by the legend to top left of each
graph). The IL-6 values were corrected for mean baseline IL-6 levels seen in unstimulated cells. Unpaired two-tailed t-tests have been performed
(n = 3). NS = not significant. * p < 0.05, **p < 0.01, *** p < 0.001.
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live Chlamydia treatments compared to individual cell
cultures (Figure 1B). Co-culture of Ecc-1 cells with
THP-1 resulted in an increase of IL-6 levels compared
to Ecc-1 or THP-1 cells alone when stimulated with the
chlamydial proteins or UV killed Chlamydia. Once again
the IL-6 production from co-cultures (Ecc-1 and THP-1)
with live Chlamydia did not show increased levels
compared to either cell line alone (Figure 1C). Very little
IL-6 was produced by Ishikawa cells alone, and regard-
less of the antigen added, the co-culture of Ishikawa cells
with THP-1 resulted in comparatively reduced IL-6
levels, similar to the observation for HeLa co-cultures
(Figure 1D). The HeLa and HEp-2 cell co-cultures
generated far greater levels (10 to 100-fold) of IL-6 in
response to the proteins or Chlamydia than the Ecc-1
and Ishikawa cells.
Combined this data demonstrates that the different
reproductive cell culture laboratory models react differ-
ently to Chlamydia or chlamydial antigens, and that the
interaction between epithelia and live-mononuclear cel-
lular cultures to produce IL-6 appears to be modulated
by the presence of live Chlamydia. Importantly, the live
Chlamydia used during this study is the aggressive
lymphogranuloma venereum strain L2, therefore the
modulation of the IL-6 response in co-culture may be
specific to this strain, however the sustained IL-6
production was observed under all conditions using
either recombinant protein PAMPs and UV killed or live
Chlamydia suggesting IL-6 prolonged response is a key
component of the innate response to Chlamydia. The
variable levels in each cell line suggest host specific
variability which may indicate an underlying disease sus-
ceptibility which we decided to investigate further using
primary culture models.
Primary cultures of female reproductive tract tissues
produced IL-6 in response to chlamydial stress response
proteases
Primary human endometrial and endocervical cells were
isolated and cultured with co-cultures of autologous
PBMC to monitor cytokine responses to the stimulants
(four participants). The cultures were monitored for the
presence of IL-6, IL-1β, IL-4, IL-10, IL-12, IL-13 and
IFN-γ in the supernatant 96 h after addition of theproteins or Chlamydia. As observed for the laboratory
cell model experiments presented in Figure 1, IL-6 was
detected during all conditions tested. Minor amounts of
IL-1β and IFN-γ were detected in some cases, in the
range of 0–20 pg/ml and therefore not at clinically
relevant levels (data not shown). None of the other
cytokines tested were detectable at 96 h (i.e. IL-4, IL-10,
IL-12, and IL-13),
The IL-6 levels produced by the epithelia and PBMC
varied between ~150 pg/ml and 21 000 pg/ml between
different participants, indicating that the IL-6 response
varies widely between individuals. Cell isolation proto-
cols, cell numbers cultured, and concentration of pro-
teins added were identical for each condition, as detailed
in the Methods. This considerable variation in IL-6
levels means that pooled participant data does not fairly
represent the distribution of data observed; hence for
clarity and accurate representation of the data, individual
participant data has been separately presented in Figure 2.
IL-6 levels secreted in response to the chlamydial proteins
(CtHtrA and CtTsp) were generally observed to be greater
when PBMC and either endometrial or endocervical cell
co-cultures were stimulated (Figure 2) compared to each
of the cell types cultured and stimulated separately.
However, endocervical and endometrial cell co-cultures
with autologous PBMC from two of the four participants
showed this enhanced response to CtHtrA but not to
CtTsp indicating that for each different participant
primary reproductive epithelial cell culture differentially
responds to different chlamydial PAMPs.
In three of the four primary cell cultures, the levels of
IL-6 induced by the presence of live Chlamydia was not
increased during the PBMC and endocervical or endo-
metrial co-cultures compared to the individual epithelial
or PBMC cell cultures and in some cases the co-culture
of these cells actually showed a mildly reduced amount
of IL-6 in response to live-Chlamydia. This is similar to
the dichotomy in results found for HeLa and HEp-2
cells when co-cultured with THP-1 cells in vitro and
stimulated with either the chlamydial proteins (CtHtrA
and CtTsp) or live Chlamydia. Three of the four primary
PBMC cultures were found to produce higher IL-6 levels
in response to either the protein or chlamydial stimu-
lants, than the corresponding participants’ endometrial
or endocervical cells. The exception was tissue sourced
Figure 2 (See legend on next page.)
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Figure 2 IL-6 responses in primary cultures of hysterectomy tissue. IL-6 response detected from primary reproductive cell culture from four
separate participants. The graphs show the cellular responses to CtHtrA, CtTsp, live Chlamydia and UV-killed Chlamydia from endometrial, endocervical,
and PBMC primary cultures from human participants. There was a significant variation in the amount of IL-6 secreted; therefore each participant’s data
has been shown as separate graphs. A) Participant code QUTPRT02, B) Participant code QUTPRT03, C) Participant code QUTPRT05 and D) Participant
code QUTPRT05. Each sample IL-6 value has been corrected for mean baseline of IL-6 from unstimulated cells (n = 2 repeats for each sample).
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following stimulation of endometrial and endocervical
epithelial cells (approximately 10–100 fold higher).
Participant peripheral blood mononuclear cells respond
to chlamydial stress response proteases independent of
disease cohort
In order to further understand the role PBMCs may have
in the immune response to these chlamydial antigens, we
examined a larger selection of participant PBMC res-
ponses to the antigens and Chlamydia. PBMCs from
participants were isolated and stimulated with CtHtrA
and CtTsp (previously described cohorts [11,24]), cyto-
kines were measured at 96 h. The participants were
grouped into the following disease cohorts; acute C.
trachomatis infection, C. trachomatis tubal factor infer-
tility, infertile C. trachomatis unrelated (C. pneumoniae
serological status was tested and this cohort was split into
two depending on this results). We also analysed cHSP60
and observed similar responses as previously reportedFigure 3 Production of cytokines from PBMCs stimulated with CtTsp
isolated from patients belonging to either Infertile (Cpn negative refers to
(Cpn positive or serologically positive for C. pneumoniae IgG MEDAC ELISA,
in vitro with A) CtTsp and B) CtHtrA, and IL-6 levels detected in supernatan
performed between cohorts and no significant differences were seen. The
acute infection n = 4, Tubal factor infertility n = 3.[22,23,25]. We analysed all PBMC data using heatmaps
clustered by cytokine and patient responses to observe
correlated cytokine and participant (cohort) responses
(Additional file 2: Figure S2). No significant difference was
observed for the types of cytokines induced by either
CtHtrA or CtTsp from the participants belonging to the
different disease cohorts (Figure 3). Infertile women (not
chlamydial induced) who had no serology against or
reported history of C. trachomatis or C. pneumoniae
infections produced the highest levels of cytokines in
response to these proteins, including IL-6 (Figure 3). The
range of concentrations of cytokines produced in response
to these proteins was very broad in the acute infection
cohort, suggesting that there may well be differential
adaptive cellular immune responses to these proteins in
this population which results in different levels of cytokine
induction. However, PBMCs isolated from women who
had not been exposed to either C. trachomatis or C. pneu-
moniae actually produced the highest levels of IL-6 pro-
viding further weight to the evidence that CtHtrA andand CtHtrA according to participant cohort. PBMCs were
serologically negative for C. pneumoniae IgG MEDAC ELISA), Infertile
Acute chlamydial infection or TFI cohorts. PBMCs were stimulated
ts after four days of culture. Unpaired two-tailed t-tests have been
cohort numbers were: Infertile Cpn neg n = 7, infertile Cpn pos n = 4,
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from both epithelial and mono-nuclear cells. There was a
trend for the chlamydial tubal factor infertility cohort
PBMCs to secrete lower concentrations of cytokines in re-
sponse to CtHtrA and CtTsp, with the exception of IL-10.
Other cytokines which were tested for but not detected in
any patient cohort were IL-13, IL-12, and IL-4. PBMCs
from the participant cohort with no prior chlamydial
exposure showed a tendency towards a more inflamma-
tory cytokine profile, with higher levels of IL-6, IL-1β and
IFNγ. These data imply that CtTsp and CtHtrA have con-
served PAMPs which are recognised by mononuclear cells
and which could drive a pathological immune response.
Induction of IL-6 by Chlamydia, and the secreted prote-
ases CtTsp and CtHtrA involves MEK1/2 MAP kinases
The sustained induction of IL-6 by the epithelial cells
observed here and the modulation of this in the pres-
ence of monocytic cells is similar to what has been
reported for chronic inflammatory diseases of the gut,
Crohns disease and ulcerative colitis. In these inflamma-
tory diseases the intestinal epithelial production of IL-6
is increased by the presence of macrophages and CD4+
T-cells [26] and the presence of the pro-inflammatory
cytokine IL-1β [27]. In order to understand if the IL-6Figure 4 Dependence of HeLa IL-6 and IL-1β response on cellular sign
HeLa with THP-1 cultures in response to the various stimulants is shown in
A) HeLa. B) HeLa with THP-1 co-culture. C) HeLa IL-1β response at 24 h an
two-tailed t-tests have been performed between cohorts.observed in these experiments similarly occurs as a con-
sequence of prior secretion of IL-1β and the immune
pathways involved, the laboratory model cultures of
HeLa and HeLa co-culture with THP-1 were repeated
using a variety of immune pathway modulators (24 h for
IL-1β and 96 h for IL-6).
A caspase-1 inhibitor was tested because caspase-1
initially activates IL-1β as part of the inflammasome
response (reviewed [28]). Inhibition of caspase-1 actually
resulted in increased IL-6 production in response to all
stimulants (Figure 4), but in HeLa only cultures there
was no effect on the IL-6 secretion except in response to
live Chlamydia where the levels also significantly increa-
sed (Figure 4). Wedelolactone inhibits IKK, a kinase
involved the final stages of NF-κB activation cascade
[27]. IKK inhibition did not alter the IL-6 levels secreted
into the media under any of the culture conditions
(Figure 4). PD98059 is a broad MEK inhibitor which
results in decreased downstream JNK, STAT and p38
pathways induction (reviewed, [29]). U0126 inhibits
MEK1/2, leading to decreased ERK1/2 signalling. Broad
MEK inhibition did decrease the IL-6 secretion in
response to CtHtrA, CtTsp, and live Chlamydia in the
HeLa only cell culture (Figure 4). In the co-culture
model, IL-6 secretion in response to CtHtrA and CtTspalling pathways. The secretion of IL-6 into the media from HeLa or
the graphs. The IL-6 response at 96 hours is shown in Fig A and B.
d D) HeLa and THP-1 co-culture IL-1β levels at 24 h. (n = 3) Unpaired
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MEK1/2 inhibition (U0126) (Figure 4).
In the co- culture model experiments (HeLa and
THP-1) the production of IL-1β was significantly
dependent on NF-κb (wedelolactone addition resulted in
reduced IL-1β secretion) in response to both CtHtrA
and CtTsp proteins. IL-1β secretion from HeLa and
THP-1 co-cultures in the presence of the MEK inhibi-
tors was also generally reduced (significantly in response
to CtTsp, UV killed Chlamydia and live Chlamydia).
Hence, the MEK pathways under which IL-1β secretion
was reduced also showed a reduced IL-6, supporting that
a higher IL-6 response may be preceded by Il-1 produc-
tion. However, direct signalling to NF-κb also induced
IL-1β (wedelolactone) and this pathway was not required
for the secretion of IL-6, thus there are several distinct
pathogen recognition pathways that can be activated
by Chlamydia or chlamydial components to induce
an IL-1β response.
IL-6 and other pro-inflammatory cytokines are induced in
mice reproductive tissues
The mouse model has been widely used to attempt to
investigate the factors involved in chlamydial immuno-
pathology. Interestingly, a previous investigation of IL-6
knockout mice did not find a difference in pathological
outcome compared to the wild-type [30]. However, the
IL-6 knockout mice are of a genetic background that
includes C57BL/6 which are now known to have much
less frequent development of pathology in response to
Chlamydia [31]. Therefore, it is likely that an IL-6
knockout in a different genetic background may show a
different result. We set out to validate that mouse epi-
thelia also produce IL-6 in response to Chlamydia and
the mouse Chlamydia (Chlamydia (C.). muridarum)
homologous stress response proteases as a proof of
concept for potential future IL-6 investigations in a
different mouse model. These proteins are closely
conserved between the two strains, with CtHtrA and
CmHtrA sharing 96% identical amino acids (482/497)
and 93% similarity (462/497), and CtTsp and CmTsp
sharing 90% identity (580/642) and 95% (615/642) simi-
larity of amino acid sequence. Firstly, we validated that
the C. muridarum homologs induce an IL-6 response in
the human cells. Ecc-1 cells were used for this initial com-
parison. There were no significant differences between
CmHtrA and CtHtrA induced IL-6 secretion, and CmTsp
induced higher levels of IL-6 than CtTsp (Additional file
3: Figure S3).
Mice fibroblasts (McCoy) and mice macrophages
(RAW264.7) were then tested to ensure the C. muri-
darum proteins also induce IL-6 from mice cells. Other
than IL-6 we were able to detect IL-10, GM-CSF, TNFα
production in response to the proteins and Chlamydia(Additional file 4: Figure S4). None or physiologically
irrelevant levels of cytokine was detected for IL-2, IL-4,
IL-5, IL-6, IL-12, or IFN-γ under all conditions. The
secreted levels of IL-6, IL-10, GM-CSF, and TNFα were all
increased in the co-culture models compared to individual
cell cultures when the stimulant was CmHtrA or CmTsp
(Figure 5, and Additional file 4: Figure S4). However, for
live Chlamydia the amount of IL-6 was reduced in co-
culture models compared to the mono-cultures alone
(Figure 5), consistent with what we already observed with
the human cell culture models (Figures 1 and 2).
In order to assess if these observations reflect the local
response in the mouse genital tract a primary culture
model was conducted where uterine tissue and the local
caudal lymph node from naïve mice was isolated, cul-
tured and exposed to the stimulants and secreted cyto-
kines measured, at 96 h. The predominant cytokine
detected was IL-6 from both uterine horn and lymph
node primary tissue in response to CmTsp, CmHtrA,
live Chlamydia and UV killed Chlamydia (Figure 5B).
GM-CSF was also detected to be produced in response
to the proteins and Chlamydia stimulants by the pri-
mary culture of uterine horns. CmTsp induced strong
IL-6 responses from both these tissues and the labora-
tory model cell cultures. IL-6 and IL-5 production was
generally higher from lymph node tissues, whereas IL-6,
IL-5, IL-10 and GM-CSF were higher from the uterine
horn cell cultures. Therefore IL-6 produced by both
human and mice species in response to their respective
Chlamydia strains and two exported stress response
proteases (Tsp and HtrA) may be a contributor to the
innate cellular response to this pathogen and develop-
ment of pathology.
Discussion
This study has observed that the IL-6 response to Chla-
mydia and chlamydial PAMPs (in this case two stress
response protease CtTsp and CtHtrA) varies widely in
different reproductive cultures, which may implicate the
level of IL-6 response as one of the factors which deter-
mines the disease outcome in women. The IL-6 was
strongly induced by the proteases Ct/CmTsp and Ct/
CmHtrA, live and UV killed Chlamydia in epithelial and
mono-nuclear cell cultures. Live Chlamydia but not UV
killed Chlamydia resulted in a reduced amount of IL-6
secreted when mononuclear and epithelial cells were co-
cultured, suggesting that perhaps signalling for IL-6
induction may be yet another immune pathway for which
Chlamydia has evolved a mechanism for immune-modula-
tion. Secretion of IL-6 by epithelia and mononuclear cells
in response to Chlamydia has been previously observed
[32]. The co-culture based modulation of IL-6 has been
previously observed by others at a day 3 time point follow-
ing Chlamydia cultures in the presence of HeLa cells and
Figure 5 Mouse cells produce IL-6 in response to the chlamydial stress response proteases and Chlamydia. A) The figure shows the IL-6
production from mouse laboratory cell culture mono-layers with McCoy and co-culture with RAW264.7 cells in response to the stimulants. B) The
graph shows the IL-6 production by primary uterine horn and caudal lymph node mouse cell culture in response to the stimulants. Stimulants
are indicated to the right of each graph by the shaded bars (n = 2).
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ential levels of IL-6 from primary human reproductive
tissue and differential co-culture effects from human and
animal models. The sustained nature of this response is
also potentially important. Cytokines commonly reported
in the literature has being detected at 24 and 48 h after
chlamydial addition to PBMC [19,22,25], laboratory models
or primary cultures were not detected at the 96 h time
point, all though consistent with the previous literature
when we did look for IL-1β at 24 h (as previously reported
[19,21,25]) in our model we did detect this cytokine.
Therefore, our model overall is consistent with previous
findings, however, the extended time point we used could
be important given the sustained presence of IL-6. This
implies that IL-6 is a prolonged or sustained response to
Chlamydia compared to many other cytokines, which is
likely important in the disease setting.
Preliminary data presented here indicates that the IL-6
induction in response to the externally supplemented
chlamydial stress response proteases and live chlamydial
infections involved MEK pathways. The presence ofIL-1β or GM-CSF along with (or prior to) IL-6 in the
human or mouse culture models (respectively) sug-
gests that IL-6 is involved in the innate pathological
response to Chlamydia. Given that the IL-6 was detected
in response to these antigens during primary cell cultures
of reproductive epithelia from human participants, this
data further supports the cellular paradigm of chlamydial
disease pathology, that is the initial innate cellular res-
ponse to the Chlamydia, and/or potentially exported
chlamydial PAMPs such as CtTsp and CtHtrA can drive a
pathological immune process leading to tissue damage,
and IL-6 may be a cytokine involved in this disease mech-
anism. Both the sustained (until 96 h when most other
cytokines were not detected) and the variability in concen-
tration of IL-6 observed between different individuals also
supports this possible role for IL-6 given that we know the
infection outcome varies between individuals.
The induction of IL-6 was also detected when parti-
cipant PBMCs were isolated and stimulated with the
proteins or Chlamydia. Given that there were no signi-
ficant cohort differences, it appears that these CtTsp and
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nised by innate pathogen marker receptors on human
immune and epithelial cells. The trend towards higher
levels of inflammatory cytokines in previously unexposed
patients appears to be consistent with the results seen in
primary cell culture, where IL-6 but no IL-10, IL-4 or
IL-5 was detected. Others have shown cohort-specific
differences in cytokine response for different chlamydial
PAMPs suggesting that some other chlamydial PAMPs
drive an adaptive and pathological immune response.
For example, PBMCs from Chlamydia-positive infertile
women secreted more IL-6, IL-10 and IL-1β in response
to Inc proteins than PBMCs from Chlamydia-positive
fertile women [33]. The data presented here suggests
that the co-interaction between epithelial and immune
cells has a greater effect on immunopathological out-
comes than monocytic or epithelial cell responses alone.
Thus, measurement of cytokine release from stimulated
PBMC may not sufficiently reflect the local cytokine
milieu in the reproductive tract during infection. In par-
ticular the ability of live Chlamydia (but not UV killed)
to reduce the IL-6 response during co-culture models
may imply that IL-6 production is a host pathway
targeted by this organism.
Conclusions
We have identified a potential role for Chlamydia and
chlamydial stress response proteases in the induction of
differing levels of IL-6 from reproductive epithelia which
may be involved in the damaging disease process. IL-6 was
induced from both peripheral mononuclear cells and epi-
thelial cells from primary human cultures with large varia-
tions in the concentration induced. IL-6 was also detected
when the mouse homolog proteins were tested against
primary mouse cell cultures. Combined these data suggest
that IL-6 is induced during the innate response to Chla-
mydia and HtrA and Tsp. Therefore, the chlamydial stress
response proteases HtrA and Tsp have conserved PAMPs
which induce IL-6 and could be antigens which play a role
in the development of disease pathology in some women.
There was no evidence from the PBMC data of a cohort
specific IL-6 response to CtHtrA or CtTsp. Therefore, the
large variation in IL-6 response by the epithelial and un-
exposed mononuclear cells to these antigens and the whole
chlamydia suggests that there may be a pre-disposed likeli-
hood of a high or low innate immune IL-6 response which
may be an important factor in disease outcome from chla-
mydial infection. There were also different IL-6 responses
during co-cultures with mononuclear cells from different
participant epithelia or lab cell models compared to epithe-
lia alone, in some cases the IL-6 response to Chlamydia
was dampened by the co-culture, further supporting that
the individual IL-6 response could be a major factor in the
modulation of chlamydial infection disease outcome.Additional files
Additional file 1: Figure S1. HeLa cell model including the cHSP60
induced cytokine response.
Additional file 2: Figure S2. Cytokine secretion after stimulus with
cHSP60 (A), HtrA (B) or TSP (C) for individual patient samples with hierarchical
clustering of samples (x axis) and inflammatory cytokines (y axis). Patient
cohort (infertile Cpn negative - light blue, Infertile Cpn positive - dark blue,
acute - red, TFI - yellow) and cytokine type (humoral - black, cytotoxic - white)
are denoted for each sample on the top and left axes, respectively. (D) cHSP60
cytokine response shown graphically as pooled cohort data, as shown for
other proteins in Figure 3.
Additional file 3: Figure S3. Comparison of mouse and human
Chlamydia stress response proteases as antigens with Ecc1 cells.
Additional file 4: Figure S4. Primary mouse tissue cytokine responses
to the stimulants.
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